Paper
0
Comparative Analysis of Outcomes with HMA Plus Venetoclax Vs Intensive Chemotherapy in AML Patients Harboring Very-High Risk Cytogenetics
Authors
Luis Aguirre,Jan Bewersdorf
Yiwen Liu,Rory Shallis,Leora Boussi,Andrius Žučenka,Sylvain Garciaz,Rebecca Bystrom,Daniel DeAngelo,Richard Stone,Marlise Luskin,Jacqueline Garcia,Eric Winer,Kelly Ling,Evan Chen,Martha Wadleigh,Eytan Stein,Aaron Goldberg,Amer Zeidan,Shai Shimony
+18 authors
,Maximilian StahlJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.